Introduction
Besides iPTH, the most commonly explored biochemical serum markers of bone remodelling are listed in Table 1 . Chronic renal failure (CRF ) is often associated with bone disorders (renal osteodystrophy) including secondary hyperparathyroidism, mixed uraemic osteodys-Biochemical serum markers of bone formation trophy, low turnover osteomalacia, adynamic bone disease, aluminium toxicity-related osteopathy and Alkaline phosphatase (AP) is a glycosylated protein b2-microglobulin bone deposition. Bone histology produced by at least five different organs: liver, bone, remains the gold standard for the diagnosis of renal kidney, intestine and placenta. In bone, AP is produced osteodystrophy, and the distinction between high and by osteoblasts and osteoblast precursors, and participlow bone turnover disease in these patients frequently ates in the mineralization process. Several laborious requires invasive and costly methods such as bone and time-consuming techniques have been used to histomorphometry (including static and kinetic varidetect the osteoblast enzyme, bone-specific alkaline ables after double tetracycline labelling).
phosphatase (bAP), and to enhance the sensitivity of The ideal biochemical marker of bone turnover this marker, including: heat inactivation, wheat germ should be unique to bone, reflect total skeletal activity lectin or concanavalin A precipitation, inhibition by and be well correlated with histomorphometric and amino acids and urea, high-performance affinity chroradiocalcium kinetics results. We are still looking for matography and agarose gel electrophoresis. The devela specific and sensitive serum biochemical test for opment of monoclonal antibodies specific for bAP monitoring bone turnover in uraemia. During the last provided the basis for a more specific index of bone years, several enzymes and matrix proteins synthesized formation [5] . by osteoblasts, and protein fragments released after
In a recent study, in 42 haemodialysis patients, we bone matrix breakdown, have been proposed as serum showed that plasma bAP (measured with a new direct biochemical markers of bone formation and bone immunoradiometric assay-IRMA) was better correlresorption. The interpretation of serum or plasma ated with bone formation and bone resorption histoconcentrations of these markers is hindered, in CRF, morphometric parameters than iPTH or total AP [6 ] . by different factors (circadian rhythms, diet, age, Values of bAP >20 ng/ml had a sensitivity of 100% gender, menopause, liver function, clearance rates). and a specificity of 100% for the diagnosis of HTBD, The development of highly precise radioimmunoand there was an excellent correlation between plasma metric assays for intact parathyroid hormone (iPTH ) bAP and the bone formation rate (BFR). When these in the last decade has shown that measurement of limits of bAP values were associated with serum iPTH iPTH is a useful predictor of bone histology and can >200 pg/ml, the positive predictability value for the serve as a non-invasive tool in distinguishing between diagnosis of HTBD increased from 84 to 94%. These high turnover (HTBD) and normal or low turnover results have been confirmed by other groups not only bone disease (N/LTBD) when large groups of patients in HTBD patients [7] , but also in the diagnosis of are considered [1]. However, in an individual patient, adynamic bone disease (ABD) [8] , in the latter case by using the agarose gel electrophoresis method for A. Ferreira 30 (38% of their patients) [14] , also indicating a relatively low specificity and lack of responsiveness of PICP.
Osteocalcin (BGP) represents one of the most abundant non-collagenous bone proteins, but is also Biochemical serum markers of bone resorption present in dentin and calcified cartilage. It is produced by osteoblasts and has been regarded as a marker of bone formation. Serum intact osteocalcin seems to Tartrate-resistant acid phosphatase represents the fraction of acid phosphatase that shows resistance, in its reflect the excess of produced protein not integrated in bone matrix. The new immunoradiometric assays, mobility on acrylamide gel, to inhibition by tartrate. This is a feature of the bone acid phosphatase, but the which use specific monoclonal antibodies to measure only intact osteocalcin [9], may be more accurate, degree of specificity to osteoclasts is not well defined, and a similar fraction enzyme is produced by other since they will exclude BGP fragments. Nevertheless, BGP suffers from poor stability and is removed via cell types [15] (as we can see, for instance, in hairy cell leukaemia and Gaucher's disease). The recent developthe kidneys. After the menopause, its serum concentrations increased less that those of bAP, showing inferior ment of immunoassays for this enzyme molecule should offer increased specificity, but clinical data is still sensitivity in the diagnosis of bone turnover in this osteopathy [10] .
insufficient [16, 17] . Assays for type I collagen cross-linked telopeptide Procollagen type I carboxy-terminal propeptides (PICP) have been used as serum markers of bone (ICTP) using a polyclonal antibody have been developed [18] but with disappointing clinical results formation since they are by-products of collagen synthesis, and collagen type I is the most abundant protein [10] . Its elimination rate depends on the glomerular filtration rate, and its serum levels respond poorly to of bone, accounting for >90% of the proteins of bone matrix. In pre-dialysis chronic renal failure, PICP hormone replacement therapy after menopause [19] .
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In our dialysed patients, we did not observe a signific-iliac bone biopsy, and to compare such levels with bone histomorphometric findings [27] . We found an ant correlation between serum ICTP and any static or dynamic histomorphometric parameter, suggesting inverse relationship between IL-1 receptor antagonist and osteoblast surface, as well as between osteoclast that ICTP is not a sensitive marker of bone metabolism in uraemia [12] . On the contrary, Mazzaferro et al. surface and soluble IL-6 receptor/IL-6 ratio. These preliminary findings support the hypothesis that the found ICTP serum levels correlated to serum AP, bAP, iPTH and to some histomorphometric indices of bone cytokine/cytokine receptor/receptor antagonist network may play a relevant role in the pathogenesis of turnover, and pointed out ICTP as a useful humoral marker of bone turnover in dialysis renal osteodys-renal osteodystrophy, and that the serum levels of some of these local mediators might reflect activity of trophy [13] .
Pyridinoline cross-links of collagen exist under two the bone cells.
In conclusion, the evaluation of bone turnover chemical forms: hydroxylysylpyridinoline (or pyridinoline-Pyr) and lysylpyridinoline (or deoxypyridino-should include a combination of different markers, so that the balance between bone formation and bone line-Dpy). These molecules are markers of type I and type II collagen breakdown, and their urinary resorption can be evaluated adequately. The immunoassays of human bAP for bone formation and of Pyr excretion has already been validated as an excellent marker of bone resorption in several metabolic bone for bone resorption seem to be currently the most sensitive and specific serum markers of bone turnover diseases. We have demonstrated recently, for the first time, that serum Pyr concentrations can be measured in renal osteodystrophy. These markers should be combined with serum iPTH, with serum b2M and with reliably with an accurate competitive enzyme immunoassay [20] in dialysis patients, and that these patients serum aluminium. Finally, in the presence of previous aluminium overload, a bone biopsy frequently is had markedly increased serum Pyr compared with normal individuals. Among our 37 haemodialysis needed to determine the exact type of bone lesion, and to quantify the aluminium bone deposits. patients, those with the highest rate of bone resorption showed the highest values of serum Pyr. We observed a good correlation between serum Pyr, the number of osteoclasts/mm2 and the percentage of bone covered References by osteoclasts [12] .
Besides the biochemical serum markers of bone of bone cells or another marker of bone cell activity.
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The involvement of cytokines and their inhibitors in 
